KARI COATS: Open Payments
NPI 1356803860 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 35 payments from 14 companies in 2025. Trend: 2023 $681 · 2024 $427 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $219 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| CSL Behring | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| GENZYME CORPORATION | 2 | $39 |
| Verona Pharma, Inc. | 2 | $38 |
| Viatris Specialty LLC | 1 | $29 |
Products named: AIRSUPRA, DUPIXENT, Hizentra, TRELEGY ELLIPTA, NEFFY, BREZTRI, NUCALA, TEZSPIRE.
Industry payments across NM — which companies pay providers there.
